The role of natural killer cells in combinatorial anti-cancer therapy using Sindbis viral vectors and irinotecan

Cancer Gene Therapy

Volumn 19, Issue 8, 2012, Pages 588-591

  Granot, T ^a   Meruelo, D ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

irinotecan; NK cells; ovarian cancer; Sindbis

Indexed keywords

IRINOTECAN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLUMINESCENCE; CANCER RESISTANCE; CANCER THERAPY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LONG TERM SURVIVAL; MOUSE; NATURAL KILLER CELL; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; SCID MOUSE; SINDBIS VIRUS; THERAPY EFFECT;

ANIMALS; CAMPTOTHECIN; FEMALE; HUMANS; KILLER CELLS, NATURAL; MICE; MICE, SCID; NEOPLASMS, EXPERIMENTAL; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; OVARIAN NEOPLASMS; SINDBIS VIRUS; TOPOISOMERASE INHIBITORS;

ANIMALIA; MUS;

EID: 84864117828     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2012.33     Document Type: Article

References (10)

1. Morton CL, Iacono L, Hyatt JL, Taylor KR, Cheshire PJ, Houghton PJ et al. Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice. Cancer Chemother Pharmacol 2005; 56: 629-636. (Pubitemid 41425060)
2. Tseng JC, Levin B, Hurtado A, Yee H, Perez de Castro I, Jimenez M et al. Systemic tumor targeting and killing by sindbis viral vectors. Nat Biotechnol 2004; 22: 70-77. (Pubitemid 38057959)
3. Prestwich RJ, Harrington KJ, Pandha HS, Vile RG, Melcher AA, Errington F. Oncolytic viruses: a novel form of immunotherapy. Expert Rev Anticancer Ther 2008; 8: 1581-1588.
4. Granot T, Venticinque L, Tseng JC, Meruelo D. Activation of cytotoxic and regulatory functions of NK cells by Sindbis viral vectors. PLoS One 2011; 6: e20598.
5. Stubdal H, Perin N, Lemmon M, Holman P, Bauzon M, Potter PM et al. A prodrug strategy using ONYX-015-based replicating adenoviruses to deliver rabbit carboxylesterase to tumor cells for conversion of CPT-11 to SN-38. Cancer Res 2003; 63: 6900-6908. (Pubitemid 37322974)
6. Liu LF, Desai SD, Li TK, Mao Y, Sun M, Sim SP. Mechanism of action of camptothecin. Ann NY Acad Sci 2000; 922: 1-10. (Pubitemid 32050237)
7. Morris EJ, Geller HM. Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity. J Cell Biol 1996; 134: 757-770. (Pubitemid 26269145)
8. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008; 9: 503-510. (Pubitemid 351560519)
9. Gonzalez S, Lopez-Soto A, Suarez-Alvarez B, Lopez-Vazquez A, Lopez-Larrea C. NKG2D ligands: key targets of the immune response. Trends Immunol 2008; 29: 397-403.
10. Xu Y, Villalona-Calero MA. Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity. Ann Oncol 2002; 13: 1841-1851. (Pubitemid 36040772)